Scroll back to the halcyon days of 2020, when the Internet was overflowing with self-love sermons, plus-size runway shows, and pastel infographics reminding us to “embrace every curve.” Now ...

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, ...

No one doubts that they reduce insulin resistance, effectively treating t ype 2 diabetes. But t ype 2 diabetes isn’t just an insulin or blood sugar disease—it has many other possible effects.

Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts ...

A knock-on effect from the use Ozempic is a change of diet, including a reliance on caffeine and low carbs. However, this ...

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...